SYNCOOP

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Nov 2024 filing date already counts against anyone who files later.

Record

Serial number

98851304

Mark type

Stylized text

Filed

13 Nov 2024

Published for opposition

07 Oct 2025

Attorney of record

William C. Wright

Goods and services

• Class 009 — Scientific and electric apparatus: Downloadable bioinformatics software for storing, indexing, searching, retrieving, and accessing information about biological data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug discovery, drug development, and drug manufacturing; downloadable chemoinformatics software for storing, indexing, searching, retrieving, and accessing information about chemical compounds and chemical data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; downloadable software for use in biological and chemical modelling, analysis and information management for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; downloadable software for computer-aided molecular design, data processing and data analysis for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; downloadable chemical data analysis software for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; downloadable drug discovery information systems software used to solve problems in connection with chemical syntheses for use in the field of organic chemistry; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
• Class 038 — Telecommunications services: Providing access to databases for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
• Class 042 — Scientific and technological services: Biotechnology and pharmaceutical research relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug development; professional consultancy in relation to drug development; scientific research and development for others; scientific research in the nature of analysis and preparation of data relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery and drug development; provision of scientific information in relation to drug discovery and drug development; provision of scientific information related to pharmacy; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
• Class 045 — Legal and security services: Licensing of computer software used for retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy

Owner

• MERCK KGAA, Darmstadt, DE
• MERCK KGAA, Darmstadt, DE

Prosecution history

• 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 07 Oct 2025 — PUBLISHED FOR OPPOSITION
• 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 06 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 20 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 20 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 20 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 20 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 20 May 2025 — NON-FINAL ACTION E-MAILED
• 20 May 2025 — NON-FINAL ACTION WRITTEN
• 08 May 2025 — ASSIGNED TO EXAMINER
• 26 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 13 Nov 2024 — NEW APPLICATION ENTERED